There are specific treatment options patients may qualify for depending on the cytogenetic or molecular abnormality detected.
Katelyn Yamartino, PharmD
Advertisement
Articles by Katelyn Yamartino, PharmD
Advertisement
Latest Updated Articles
Utilizing Pharmacogenomics Information to Guide AML TreatmentPublished: March 3rd 2021 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Breaking News: CVS Buys Rite Aid, Bartell Drugs
2
Amivantamab for EGFR-Mutated Metastatic Non–Small Cell Lung Cancer
3
FDA Approves 1-Minute HIV Self-Test
4
Young Women With Symptomatic Long COVID At Higher Risk of POTS
5
